FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to pharmaceutics and represents a pharmaceutical composition for preventing and treating osteoporosis, administered once a month and containing: (a) cholecalciferol granules, wherein (i) cholecalciferol in an amount of 24000-50000 IU; (ii) one or more ingredients specified in tocopherol acetate, butylated hydroxy toluene and butylated hydroxy anisole as a first stabilizing agent; and (iii) a binding agent adsorbed on microcrystalline cellulose, (b) mannitol as a second stabilizing agent, and (c) risedronic acid or its salt or ibandronic acid or its salt.
EFFECT: invention provides the cholecalciferol timing stability and the size reduction of the produced preparation.
14 cl, 9 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BISPHOSPHONIC ACIDS INTENDED FOR TREATMENT AND PREVENTION OF OSTEOPOROSIS | 2003 |
|
RU2387451C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF MENOPAUSE OSTEOPOROSIS IN WOMEN | 2007 |
|
RU2379043C2 |
| APPLICATIONS OF BISPHOSPHONIC ACIDS FOR OSTEOPOROSIS TREATMENT AND PREVENTION | 2003 |
|
RU2329809C2 |
| MEDICINAL FORMS ON BASIS OF BIPHOSPHONATES | 2005 |
|
RU2359678C2 |
| COMPOSITION WITH HIGH DOSE OF IBANDRONAT | 2003 |
|
RU2315603C2 |
| DOSAGE FORMS OF RISEDRONATE | 2005 |
|
RU2381791C2 |
| NEW FORMULATIONS OF 14-EPI-ANALOGUES OF VITAMIN D | 2011 |
|
RU2575819C2 |
| FORMULATIONS OF VITAMIN D 14-EPI-ANALOGUES | 2011 |
|
RU2575792C2 |
| ORAL COMPOSITIONS, PRODUCTS AND METHODS OF USE | 2008 |
|
RU2479316C2 |
| METHOD OF TREATING AND PREVENTING RESPIRATORY DISEASES INVOLVING ADMINISTRATION OF CHOLECALCIFEROL | 2008 |
|
RU2479313C2 |
